This inventor holds 4 USPTO granted patents. Top assignees: Ciba-Geigy Corporation, Novartis Ag. Active years: 1996-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2003
Title: Arco Yingcheu Jeng: Innovator in Endothelin-Converting Enzyme Research
Introduction
Arco Yingcheu Jeng is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of thiol inhibitors of endothelin-converting enzyme. With a total of 4 patents to his name, Jeng's work has implications for various therapeutic applications.
Latest Patents
Among his latest patents, Jeng has focused on "Certain thiol inhibitors of endothelin-converting enzyme." This innovative research aims to provide new avenues for treating conditions related to endothelin, a peptide that plays a crucial role in cardiovascular health.
Career Highlights
Throughout his career, Jeng has worked with prominent companies such as Ciba-Geigy Corporation and Novartis AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Jeng has collaborated with esteemed colleagues, including Stéphane De Lombaert and Cynthia Anne Fink. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Arco Yingcheu Jeng's contributions to the field of biochemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile